pyrazinamide has been researched along with Demyelinative Myelitis in 1 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Excerpt | Relevance | Reference |
---|---|---|
"Incomplete transverse myelitis (ITM) of unknown origin is associated with high rates of morbidity and mortality." | 1.37 | Mycobacteria infection in incomplete transverse myelitis is refractory to steroids: a pilot study. ( Chen, X; Feng, Y; Guo, N; Huang, F; Lai, R; Liu, J; Sun, Q, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feng, Y | 1 |
Guo, N | 1 |
Liu, J | 1 |
Chen, X | 1 |
Sun, Q | 1 |
Lai, R | 1 |
Huang, F | 1 |
1 other study available for pyrazinamide and Demyelinative Myelitis
Article | Year |
---|---|
Mycobacteria infection in incomplete transverse myelitis is refractory to steroids: a pilot study.
Topics: Adult; Aged; Antitubercular Agents; Female; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Met | 2011 |